Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
about
Adverse Effects of GLP-1 Receptor AgonistsInjection-Site Nodules Associated With the Use of Exenatide Extended-Release Reported to the U.S. Food and Drug Administration Adverse Event Reporting SystemEffect of the Glucagon-like Peptide-1 Analogue Exenatide Extended Release in Cats with Newly Diagnosed Diabetes MellitusDiabetes mellitus and the skin.Subcutaneous nodules secondary to exenatide once weekly: clinical and histological findings.Persistent injection site nodules from exenatide: Successful treatment with intralesional triamcinolone
P2860
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@en
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@nl
type
label
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@en
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@nl
prefLabel
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@en
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@nl
P2860
P356
P1476
Eosinophil-rich granulomatous panniculitis caused by exenatide injection.
@en
P2093
Mary Seabury Stone
Nicholas C Boysen
P2860
P356
10.1111/CUP.12246
P577
2013-11-14T00:00:00Z